|
Market Closed -
Sao Paulo
20:22:47 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 298.53 BRL | -3.99% |
|
-8.34% | +7.73% |
| 10-02 | S&P 500 Posts Slight Weekly Drop as Health Care, Financials Weigh | MT |
| 10-01 | Wells Fargo Adjusts Price Target on Incyte to $128 From $116, Keeps Equalweight Rating | MT |
Company Valuation: Incyte Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,213 | 17,869 | 14,072 | 13,306 | 19,391 | 23,371 | - | - |
| Change | - | 10.21% | -21.25% | -5.44% | 45.73% | 20.53% | - | - |
| Enterprise Value (EV) 1 | 13,865 | 14,630 | 10,416 | 11,148 | 16,293 | 19,095 | 17,410 | 15,438 |
| Change | - | 5.52% | -28.81% | 7.03% | 46.15% | 17.2% | -8.82% | -11.33% |
| P/E | 17.2x | 52.8x | 23.7x | 460x | 15.4x | 54x | 15.9x | 14.8x |
| PBR | 4.32x | 4.09x | 2.71x | 3.88x | 3.79x | 4.02x | 3.03x | 2.4x |
| PEG | - | -0.8x | 0.3x | -4.9x | 0x | -0.8x | 0x | 1.87x |
| Capitalization / Revenue | 5.43x | 5.26x | 3.81x | 3.14x | 3.77x | 3.93x | 3.73x | 3.56x |
| EV / Revenue | 4.64x | 4.31x | 2.82x | 2.63x | 3.17x | 3.21x | 2.78x | 2.35x |
| EV / EBITDA | 21.5x | 24.5x | 14.8x | 22.2x | 9.53x | 24.7x | 8.23x | 7.48x |
| EV / EBIT | 23.7x | 25.2x | 16.8x | 26.9x | 10.1x | 22.1x | 7.69x | 6.11x |
| EV / FCF | 24.4x | 16.4x | 22.4x | 44.8x | - | 30.6x | 10.6x | 8.82x |
| FCF Yield | 4.1% | 6.1% | 4.45% | 2.23% | - | 3.27% | 9.4% | 11.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 4.27 | 1.52 | 2.65 | 0.15 | 6.41 | 2.134 | 7.241 | 7.813 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,986 | 3,395 | 3,696 | 4,241 | 5,141 | 5,940 | 6,258 | 6,561 |
| EBITDA 1 | 643.6 | 597.7 | 703.2 | 503.1 | 1,709 | 771.9 | 2,115 | 2,064 |
| EBIT 1 | 585.8 | 579.4 | 620.5 | 413.9 | 1,616 | 863.8 | 2,264 | 2,526 |
| Net income 1 | 948.6 | 340.7 | 597.6 | 32.62 | 1,287 | 444.9 | 1,504 | 1,691 |
| Net Debt 1 | -2,348 | -3,239 | -3,656 | -2,158 | -3,098 | -4,276 | -5,961 | -7,933 |
| Reference price 2 | 73.40 | 80.32 | 62.79 | 69.07 | 98.77 | 115.30 | 115.30 | 115.30 |
| Nbr of stocks (in thousands) | 220,891 | 222,475 | 224,109 | 192,650 | 196,323 | 202,698 | - | - |
| Announcement Date | 08/02/22 | 07/02/23 | 13/02/24 | 10/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 32.45x | 11.78x | 23.93x | 0.61% | 1,019B | |
| 28.48x | 6.32x | 17.7x | 2.09% | 617B | |
| 33.26x | 7.78x | 16.08x | 2.64% | 464B | |
| 104.98x | 5.87x | 24.89x | 2.36% | 356B | |
| 18.81x | 4.58x | 11.36x | 2.9% | 333B | |
| 19.83x | 5.17x | 12.78x | 3.09% | 267B | |
| 20.02x | 4.17x | 11.86x | 2.13% | 244B | |
| 25.46x | 6.66x | 11.86x | 2.5% | 218B | |
| -43.78x | 6.39x | 24.97x | 2.27% | 179B | |
| Average | 26.61x | 6.52x | 17.27x | 2.29% | 410.8B | |
| Weighted average by Cap. | 31.80x | 7.61x | 18.61x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- INCY Stock
- I1NC34 Stock
- Valuation Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
